thenews

Grafx Announces New Project: Awareness Campaign for American Regent, Inc.

1/6/2011

American Regent, Inc. has awarded Grafx with their Awareness Campaign for Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP product. The first and only generic injectable equivalent to CELESTONE® SOLUSPAN®. This campaign will target specific markets through print advertisements, marketing materials, and direct mail pieces.

Grafx has created branded elements for Betamethasone when first being introduced to the market. Grafx is delighted to continue working with American Regent, Inc. for another successful campaign.


Share and Enjoy
  • Facebook
  • Twitter
  • Delicious
  • Digg
  • StumbleUpon
  • Add to favorites
  • Email
  • RSS

Comments are closed.